SCHEMBL14036185

SCHEMBL14036185

O=C(CCC(=O)Oc1ccccc1C(=O)O)Oc1cccc(CON(O)O)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 7/20 0.48
KMT2A Q03164 3/20 0.48
MEN1 O00255 1/20 0.48
RECQL P46063 1/20 0.48
HSD17B10 Q99714 7/20 0.41
HPGD P15428 4/20 0.41
ALDH1A1 P00352 6/20 0.40
CTSV O60911 1/20 0.40
CTSL P07711 1/20 0.40
TSHR P16473 2/20 0.40
ESR1 P03372 1/20 0.40
ITGB3 P05106 1/20 0.40
ITGA2B P08514 1/20 0.40
HMGB1 P09429 1/20 0.40
GGT1 P19440 1/20 0.40
PTGS1 P23219 1/20 0.40
PTGS2 P35354 1/20 0.40
BLM P54132 1/20 0.40
NAPRT Q6XQN6 1/20 0.40
TDP1 Q9NUW8 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14036187 0.87 KDM4E (0.51) KDM4EKMT2AMEN1RECQLHSD17B10
SCHEMBL14036098 0.84 KDM4E (0.45) KDM4EKMT2AMEN1RECQLHSD17B10
SCHEMBL14010493 0.82 KDM4E (0.46) KDM4EKMT2AMEN1RECQLHSD17B10
SCHEMBL14036097 0.78 KDM4E (0.48) KDM4EKMT2AMEN1RECQLHSD17B10
SCHEMBL13589467 0.78 PTGS2 (0.53) KDM4EKMT2AMEN1HSD17B10HPGD
Diaspirin SCHEMBL40799 0.76 KDM4E (0.75) KDM4EKMT2AMEN1RECQLHSD17B10
Diaspirin SCHEMBL30735506 0.76 KDM4E (0.75) KDM4EKMT2AMEN1RECQLHSD17B10
SCHEMBL13589569 0.74 HPGD (0.55) KDM4EKMT2AHSD17B10HPGDALDH1A1
SCHEMBL12317595 0.74 ESR1 (0.43) KDM4EKMT2AMEN1HSD17B10HPGD
SCHEMBL10145203 0.74 KDM4E (0.57) KDM4EKMT2AMEN1RECQLHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080293781-A1 Salicylic Acid Derivatives NICOX S.A. (FR) 2008-11-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080293781-A1 Salicylic Acid Derivatives PTGS2, PTGS1, PTGES2 KDM4E 2665/4885KMT2A 2780/4885MEN1 4722/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.